American Oncology Network Net Income

American Oncology Network posts a net income of $-7.6M as of December 2024. That compares with $-7.1M in the prior-year period — down 7.9% year over year. That is below the sector sector average of $90M. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, American Oncology Network's net income was $-7.1M. The latest reading is $-7.6M — a 7.9% year-over-year decrease (period ending December 2024). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a net income near $90M is typical. American Oncology Network's $-7.6M is lower that level. That is roughly 108.5% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Net Income is one piece of American Oncology Network's financial statement story. At $-7.6M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for AONC's net income usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $90M), and (3) consistency with growth and profitability. This page covers the first two; American Oncology Network's other metric pages and overview cover the third.